Previous 10 | Next 10 |
Bristol Myers Squibb (NYSE: BMY ) has settled its patent infringement litigation against Dr. Reddy's Laboratories (NYSE: RDY ) related to the latter's U.S. application seeking approval of a generic version of multiple myeloma med Revlimid (lenalidomide). More news on: Bristol-Myers S...
Dr. Reddy’s Laboratories (NYSE: RDY ) announces the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalents of Novartis' Pataday Once and Twice Daily Relief. More news on: Dr. Reddy's Laboratories Limited, He...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-...
The Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories (NYSE: RDY ) have agreed to cooperate on clinical trials and distribution of the Sputnik V vaccine in India. More news on: Dr. Reddy's Laboratories Limited, Healthcare stocks news, Read more ...
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd. (Dr. Reddy’s), a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in Ind...
It's been a painful week for growth investors given significant declines in technology-oriented indexes and exchange traded funds. The NASDAQ 100 ETF ( QQQ ) fell over 11% from its intraday high this month to its intraday low this week, and returns were worse for software investors given the...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of over-the-counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren ® Arth...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent gen...
Generic versions of a fish oil supplement proven to help reduce the risk of heart attacks took a big step toward pharmacy shelves on Thursday. A patent ruling that unravels Amarin 's (NASDAQ: AMRN) market exclusivity for Vascepa has been upheld by the U.S. Court of Appeals for the Federal Cir...
Amarin ( AMRN -3.7% ) is not yet admitting defeat in its patent infringement litigation against would-be generic Vascepa competitors Dr. Reddy's Laboratories ( RDY -0.2% ) and Hikma Pharmaceuticals. More news on: Amarin Corporation plc, Dr. Reddy's Laboratories Limited, Healthcare ...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...